Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox-sensitive mitochondrial and cytosolic proteins constitute a diverse group of proteins whose functions are regulated by the cellular reduction-oxidation (redox) state, primarily through the modification of reactive cysteine thiol groups [PMC3614623]. In the cytosol, key examples include the transcription factor Nrf2 and its inhibitor Keap1, which orchestrate the antioxidant response, as well as various protein kinases and phosphatases involved in signal transduction [PubMed: 22669173]. Mitochondrial redox-sensitive proteins include components of the electron transport chain and metabolic enzymes like aconitase, which are particularly susceptible to oxidative inactivation by reactive oxygen species (ROS) [PubMed: 15128444]. Dysregulation of these redox-sensitive pathways is implicated in the pathogenesis of cancer, where it supports survival, and in neurodegenerative diseases like Parkinson's and Alzheimer's, where oxidative damage leads to protein aggregation and cell death [PubMed: 28235565]. Pharmacological intervention typically involves electrophilic molecules that activate protective pathways (e.g., Nrf2 activators) or antioxidants designed to scavenge ROS within specific compartments like the mitochondria [PubMed: 30585954]. These proteins serve as critical redox switches that allow the cell to adapt to metabolic demands and environmental stressors.
Modulation of reactive cysteine residues and activation of endogenous antioxidant response pathways to restore redox homeostasis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox-sensitive mitochondrial and cytosolic proteins.